Lorediplon is primarily investigated for its potential use in treating sleep disorders, particularly insomnia. It functions as a GABAA receptor agonist, promoting sedation and improving sleep onset and maintenance. Research suggests it may offer a favorable safety profile with reduced next-day drowsiness compared to some existing sleep aids. Its development aims to provide an effective therapeutic option for individuals struggling with chronic sleep disturbances. Use should be under medical supervision to prevent potential addiction and side effects.